Yibin Paper: Terminate the issue of A shares to specific targets in 2022 and withdraw the application documents. Yibin Paper announced that the company held the 31st meeting of the 11th Board of Directors and the 22nd meeting of the 11th Board of Supervisors on December 12, 2024, and deliberated and passed the Proposal on Terminating the Issue of A shares to specific targets in 2022 and withdrawing the application documents. Considering the changes in market environment and policies, and considering the actual situation, the company decided to terminate the issuance of A shares to specific targets.Kweichow Moutai: The company will hold a briefing on the third quarter of 2024 from 15: 00 to 16: 00 on Tuesday, December 17, 2024.Macao celebrated the 25th anniversary of its return to the motherland with the debut of the digital MOP prototype system. In order to celebrate the 25th anniversary of Macao's return to the motherland, the "Celebrating the Successful Construction of Digital MOP Prototype System and the Release of Digital MOP White Paper" hosted by the Macao Monetary Authority was held on December 12th. It is reported that the Macao SAR, with the support of the People's Bank of China, has successfully built a prototype system of digital patacas, laying the necessary foundation for the future development of digital patacas. In the future, digital Macao pataca, as the legal tender of Macao SAR, has the same legal status and value as paper money and coins, with 100% reserve support and full legal compensation; And interoperate with various existing electronic payment systems in the Macao Special Administrative Region to realize the interconnection between wallets of different operating institutions, digital MOP wallets and bank accounts, and create a more efficient and cost-effective trading environment. (CCTV News)
Market News: South Korean President Yin Xiyue may release a recorded public speech.Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.US President-elect Trump: The Abraham Agreement will be expanded and Saudi Arabia will be added.
Nanxin Technology: The equity of shareholders Shunwei Technology and its concerted actions changed to less than 5%. Nanxin Technology announced that the shareholders of the company Shunwei Technology and its concerted actions Hangzhou Shunying, Wuhan Shunying and Wuhan Shunhong reduced their holdings of the company's shares and passively diluted their equity, and the total number of shares held by the company changed from 30,843,800 shares to 21,272,800 shares, accounting for 7.2826% to 4.9999% of the company's total share capital, no longer.CEO of STELLANTIS Europe: We will never pay a fine for the EU emission reduction requirements in 2025, and we are ready to reduce production to avoid this situation.Gobi Venture Capital announced in Shanghai that it will launch a $50 million venture capital fund to support Pakistan's technology start-ups. On December 12th, at the Pakistan Investment Summit held in Shanghai, Gobi Venture Capital, an Asian venture capital company, officially announced the launch of a $50 million fund Techxila Fund II to support Pakistan's start-ups, focusing on high-potential industries such as financial technology, e-commerce logistics and supply chain, health technology and SaaS. Gobi Venture Capital also signed a memorandum of understanding with Punjab Bank (BoP). (First Financial Reporter Qian Tongxin)
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14